Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized dosing interval exploration for zoledronic acid in primary osteoporosis
ChiCTR1900021323Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of zoledronic acid in involutional osteoporosis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Bone metabolism biochemical markers. Started Aug 2018; status: recruiting.
02
Drugs
zoledronic acid
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on ChiCTR1900021323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021323.